expert reaction to conference abstract about a phase 2 trial of a new weight loss injection, CBL-514, and levels of subcutaneous and visceral fat, presented at the European Association for the Study of Diabetes (EASD) conference in Milan
Scientists react to a conference abstract, presented at the EASD conference in Milan, about a phase 2 trial of a … read more